y 27632 has been researched along with geranylgeranyl pyrophosphate in 15 studies
Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (geranylgeranyl pyrophosphate) | Trials (geranylgeranyl pyrophosphate) | Recent Studies (post-2010) (geranylgeranyl pyrophosphate) |
---|---|---|---|---|---|
1,924 | 3 | 891 | 518 | 3 | 203 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (53.33) | 29.6817 |
2010's | 7 (46.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishibashi, T; Kimura, J; Maruyama, Y; Matsuoka, I; Nagata, K; Ohkawara, H; Sakamoto, T; Sakurada, S; Sugimoto, K; Yokoyama, K | 1 |
Ishibashi, T; Maruyama, Y; Nagata, K; Ohkawara, H; Sakamoto, T; Sakurada, S; Shindo, J; Sugimoto, K; Takuwa, Y; Teramoto, T; Yokoyama, K | 1 |
Akimoto, K; Asakawa, H; Horio, T; Matsuoka, H; Minamino, N; Mori, Y; Nishikimi, T; Tadokoro, K; Wang, X; Yoshihara, F | 1 |
Gelfanova, V; Gonzalez-DeWhitt, PA; Hale, JE; Li, B; Liu, F; May, PC; Ni, B; Paul, SM; Ryder, JW; Su, Y; Wu, X; Zhou, Y | 1 |
Fyhrquist, F; Nyman, T; Saijonmaa, O; Stewen, P | 1 |
Giri, S; Rattan, R; Singh, AK; Singh, I | 1 |
Ichihara, K; Itagaki, M; Satoh, K; Takaguri, A; Tokumitsu, Y | 1 |
Baba, TT; Miyazaki, T; Nemoto, TK; Oida, S | 1 |
Bradbury, PA; Dimitroulakos, J; Ding, K; Goss, G; Le Francois, BG; Zhao, TT | 1 |
Calzetta, L; Capuano, A; Cazzola, M; Matera, MG; Page, CP; Rinaldi, B | 1 |
Gui, Y; Jiang, J; Li, D; Li, H; Li, J; Tian, R; Walsh, MP; Wang, L; Wang, Y; Wang, Z; Yin, H; Zheng, XL | 1 |
Ieiri, I; Iwase, M; Kitazono, T; Ohdo, S; Sonoki, K; Takata, Y | 1 |
Alp Yildirim, Fİ; Ark, M; Aypar, E; Kaleli Durman, D; Özdemir, O; Uydeş Doğan, BS | 1 |
Ishihara, N; Nagayama, D; Saiki, A; Suzuki, S; Tanaka, S; Tanaka, T; Tatsuno, I; Watanabe, Y | 1 |
Ishihara, N; Nagayama, D; Ohira, M; Saiki, A; Suzuki, S; Tanaka, S; Tanaka, T; Tatsuno, I; Watanabe, Y; Yamaguchi, T | 1 |
15 other study(ies) available for y 27632 and geranylgeranyl pyrophosphate
Article | Year |
---|---|
HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells.
Topics: ADP Ribose Transferases; Amides; Aorta; Botulinum Toxins; Calcium; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Guanosine Diphosphate; Guanosine Triphosphate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracellular Fluid; Intracellular Signaling Peptides and Proteins; Lysophosphatidylcholines; Membrane Potentials; Mevalonic Acid; Patch-Clamp Techniques; Polyisoprenyl Phosphates; Protein Serine-Threonine Kinases; Pyridines; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Type C Phospholipases | 2002 |
Inhibition of Rho/Rho-kinase signaling downregulates plasminogen activator inhibitor-1 synthesis in cultured human monocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; ADP Ribose Transferases; Amides; Arteriosclerosis; Base Sequence; Botulinum Toxins; Cells, Cultured; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracellular Signaling Peptides and Proteins; Monocytes; Plasminogen Activator Inhibitor 1; Polyisoprenyl Phosphates; Pravastatin; Protein Prenylation; Protein Serine-Threonine Kinases; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases; RNA, Messenger; Signal Transduction | 2002 |
Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, inhibits cardiac myocyte hypertrophy induced by endothelin.
Topics: ADP Ribose Transferases; Amides; Animals; Atrial Natriuretic Factor; Botulinum Toxins; Cell Size; Cells, Cultured; Endothelin-1; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracellular Signaling Peptides and Proteins; Mevalonic Acid; Myocytes, Cardiac; Phenylalanine; Polyisoprenyl Phosphates; Pravastatin; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; rho GTP-Binding Proteins; rho-Associated Kinases; RNA, Messenger | 2002 |
Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho.
Topics: Amides; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartic Acid Endopeptidases; Brain; Cell Line, Tumor; Endopeptidases; Enzyme Inhibitors; Guanosine Triphosphate; Humans; Ibuprofen; Intracellular Signaling Peptides and Proteins; Mice; Mice, Transgenic; Peptide Fragments; Polyisoprenyl Phosphates; Protein Serine-Threonine Kinases; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; Sesquiterpenes; Signal Transduction; Sulindac; Transfection | 2003 |
Atorvastatin completely inhibits VEGF-induced ACE upregulation in human endothelial cells.
Topics: Amides; Atorvastatin; Cell Division; Cells, Cultured; Drug Interactions; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracellular Signaling Peptides and Proteins; Mevalonic Acid; Peptidyl-Dipeptidase A; Phosphorylation; Polyisoprenyl Phosphates; Protein Serine-Threonine Kinases; Pyridines; Pyrroles; rho-Associated Kinases; RNA, Messenger; Sesquiterpenes; Umbilical Veins; Up-Regulation; Vascular Endothelial Growth Factor A | 2004 |
Rho/ROCK pathway as a target of tumor therapy.
Topics: Amides; Animals; Antineoplastic Agents; Apoptosis; Blotting, Southern; Blotting, Western; Caspases; Cell Survival; Disease Models, Animal; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Flow Cytometry; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Intracellular Signaling Peptides and Proteins; Lovastatin; Male; Mevalonic Acid; Mice; Neoplasms; Neoplasms, Experimental; Polyisoprenyl Phosphates; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured | 2006 |
Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes.
Topics: 3T3-L1 Cells; Adaptor Proteins, Signal Transducing; Adipocytes; ADP Ribose Transferases; Amides; Animals; Atorvastatin; Botulinum Toxins; Dose-Response Relationship, Drug; Glucose; Glucose Transporter Type 4; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Receptor Substrate Proteins; Mice; Phosphorylation; Polyisoprenyl Phosphates; Pravastatin; Protein Kinase Inhibitors; Protein Prenylation; Protein Transport; Proto-Oncogene Proteins c-akt; Pyridines; Pyrroles; rab4 GTP-Binding Proteins; Receptor, Insulin; rho GTP-Binding Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; RNA, Messenger; Signal Transduction | 2008 |
Simvastatin suppresses the differentiation of C2C12 myoblast cells via a Rac pathway.
Topics: Alkaline Phosphatase; Amides; Aminoquinolines; Animals; Bone Morphogenetic Protein 2; Cell Differentiation; Cells, Cultured; Gene Expression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Muscle Fibers, Skeletal; Myoblasts, Skeletal; Myogenin; Osteoblasts; Polyisoprenyl Phosphates; Protein Kinase Inhibitors; Pyridines; Pyrimidines; rac GTP-Binding Proteins; Recombinant Proteins; rho-Associated Kinases; Sesquiterpenes; Signal Transduction; Simvastatin | 2008 |
Lovastatin inhibits EGFR dimerization and AKT activation in squamous cell carcinoma cells: potential regulation by targeting rho proteins.
Topics: Amides; Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cytoskeleton; Dimerization; Drug Interactions; Enzyme Activation; ErbB Receptors; Head and Neck Neoplasms; Humans; Lovastatin; Lung Neoplasms; Mice; NIH 3T3 Cells; Polyisoprenyl Phosphates; Proto-Oncogene Proteins c-akt; Pyridines; rho-Associated Kinases; Signal Transduction | 2010 |
Protein prenylation contributes to the effects of LPS on EFS-induced responses in human isolated bronchi.
Topics: Alkyl and Aryl Transferases; Amides; Bronchi; Bronchoconstriction; Electric Stimulation; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; In Vitro Techniques; Leucine; Lipopolysaccharides; Male; Methionine; Middle Aged; Naphthalenes; Polyisoprenyl Phosphates; Protein Kinase Inhibitors; Protein Prenylation; Pyridines; ras Proteins; rho GTP-Binding Proteins; rho-Associated Kinases; Sesquiterpenes; Signal Transduction; Simvastatin; Time Factors | 2011 |
Atorvastatin inhibits myocardin expression in vascular smooth muscle cells.
Topics: Actins; Amides; Animals; Aorta; Atorvastatin; Blotting, Western; Cell Line; Enzyme Inhibitors; Gene Expression Regulation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Male; Mevalonic Acid; Mice; Mice, Inbred C57BL; Microfilament Proteins; Muscle Proteins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nuclear Proteins; Polyisoprenyl Phosphates; Potassium Chloride; Pyridines; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; rhoA GTP-Binding Protein; Trans-Activators; Vasoconstriction | 2012 |
Statin inhibits the expression of secretory phospholipase A2 and subsequent monocyte chemoattractant protein-1 in human endothelial cells.
Topics: Amides; Chemokine CCL2; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Lysophosphatidylcholines; Phospholipases A2, Secretory; Polyisoprenyl Phosphates; Pyridines; Quinolines; RNA, Messenger; RNA, Small Interfering; Tumor Necrosis Factor-alpha | 2014 |
Atorvastatin acutely reduces the reactivity to spasmogens in rat aorta: implication of the inhibition of geranylgeranylation and MYPT-1 phosphorylation.
Topics: Amides; Animals; Aorta, Thoracic; Atorvastatin; Endothelin-1; Endothelium; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle, Smooth, Vascular; Myosin-Light-Chain Phosphatase; Norepinephrine; Phosphorylation; Polyisoprenyl Phosphates; Potassium Chloride; Prenylation; Protein Phosphatase 1; Pyridines; Rats; Rats, Wistar; rho-Associated Kinases; Sesquiterpenes | 2016 |
Atorvastatin increases Fads1, Fads2 and Elovl5 gene expression via the geranylgeranyl pyrophosphate-dependent Rho kinase pathway in 3T3-L1 cells.
Topics: 3T3-L1 Cells; Acetyltransferases; Adipocytes; Amides; Animals; Atorvastatin; Cell Survival; Delta-5 Fatty Acid Desaturase; Fatty Acid Desaturases; Fatty Acid Elongases; Gene Expression Regulation, Enzymologic; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Polyisoprenyl Phosphates; Pyridines; rho-Associated Kinases; Signal Transduction | 2017 |
Fatty acid desaturase 2 is up-regulated by the treatment with statin through geranylgeranyl pyrophosphate-dependent Rho kinase pathway in HepG2 cells.
Topics: Amides; Atorvastatin; Cell Survival; Delta-5 Fatty Acid Desaturase; Dose-Response Relationship, Drug; Eicosanoic Acids; Fatty Acid Desaturases; Fatty Acid Elongases; Gene Expression Regulation, Enzymologic; Hep G2 Cells; Humans; Mevalonic Acid; Polyisoprenyl Phosphates; Pyridines; rho-Associated Kinases; Signal Transduction; Up-Regulation | 2019 |